Personalized therapies making progress in TNB ...

oncoXchange |

octobre 2019

Targeted treatment choices expanding in TNBC

oncoXchange |

octobre 2019

Fc-engineered HER2-targeted antibody preferen ...

oncoXchange |

juin 2019

HER2 heterogeneity reduces response to HER2-d ...

oncoXchange |

juin 2019

Breast Cancer Index identifies HR-positive br ...

oncoXchange |

juin 2019

CDK4/6 Inhibitor Extends Survival in Younger ...

oncoXchange |

juin 2019

CTS5 calculator useful to guide decision to e ...

oncoXchange |

juin 2019

Surgery First? Breast Tumor Anatomy Tells the ...

oncoXchange |

mai 2019

Genetic Profiles Add Value to Breast Cancer T ...

oncoXchange |

mars 2019

Consensus Panel Favours Getting TILs Info

oncoXchange |

mars 2019